| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.2B | $0.3B | $0.2B | $0.2B | $0.0B | $0.1B | $0.1B |
| EPS (Basic) | $2.64 | $2.50 | $3.72 | $3.40 | $2.39 | $0.45 | $0.66 | $0.62 |
| EPS (Diluted) | $2.63 | $2.50 | $3.72 | $3.39 | $2.39 | $0.45 | $0.66 | $0.62 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $26.7B | $28.1B | $22.5B | $20.8B | $19.7B | $18.8B | $16.5B | $15.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.7B | $2.4B | $1.0B | $0.7B | $2.1B | $1.7B | $0.4B | $0.3B |
| Total Liabilities | $23.7B | $25.1B | $20.0B | $18.5B | $17.5B | $16.8B | $14.4B | $13.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.0B | $3.0B | $2.4B | $2.3B | $2.1B | $2.0B | $2.0B | $2.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.4B | $0.2B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B |
| Investing Cash Flow | $-0.3B | $3.3B | $-1.4B | $-2.5B | $-0.6B | $-0.9B | $-0.4B | $-0.7B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-1.6B | $-2.3B | $1.5B | $0.8B | $0.7B | $2.0B | $0.3B | $0.4B |